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AgingThe naked mole-rat maintains robust proteostasis and high levels of proteasome-mediated proteolysis for
most of its exceptional (~31 years) life span. Here, we report that the highly active proteasome from the
naked mole-rat liver resists attenuation by a diverse suite of proteasome-speciﬁc small molecule inhibitors.
Moreover, mouse, human, and yeast proteasomes exposed to the proteasome-depleted, nakedmole-rat cytosolic
fractions, recapitulate the observed inhibition resistance, and mammalian proteasomes also show increased
activity. Gel ﬁltration coupled with mass spectrometry and atomic force microscopy indicates that these traits
are supported by a protein factor that resides in the cytosol. This factor interacts with the proteasome and
modulates its activity. Although Heat shock protein 72 kDa (HSP72) and Heat shock protein 40 kDa (Homolog
of bacterial DNAJ1) (HSP40(Hdj1)) are among the constituents of this factor, the observed phenomenon, such
as increasing peptidase activity and protecting against inhibition cannot be reconciled with any known chaper-
one functions. This novel function may contribute to the exceptional protein homeostasis in the naked mole-rat
and allow it to successfully defy aging.ohexanoyl)3-(leucinyl)3-vinyl-
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The longest-lived rodent, the naked mole-rat, Heterocephalus glaber,
lives nearly an order of magnitude longer than similar-sized mice [1].
Despite high levels of oxidative stress evident even at young ages [2],
nakedmole-ratsmaintain cancer-free good health and reproductive po-
tentialwell into their third decade of life [3]. Furthermore, these rodents
show pronounced in vivo and in vitro resistance to a wide spectrum of
toxins including oxidative stressors, heavymetals, and chemotherapeu-
tics [4,5]. This is also evident at the macromolecular level withmole-rat
proteins markedly resistant to both oxidative damage and unfoldingstressors [6]. This generalized resilience against stress is likely due to
efﬁcient maintenance of protein quality control, involving both proteo-
lyticmachinery to remove damaged proteins andmolecular chaperones
[HSPs] that assist in protein repair or elimination.
HSPs bind to exposed hydrophobic regions of proteins preventing
their aggregation and promoting their correct folding [7,8]. If the pro-
cess is unsuccessful, HSPs direct protein removal via either the ubiquitin
proteasome system [UPS] or autophagy. The UPS degrades themajority
of intracellular proteins and is considered pivotal for the digest of oxida-
tively damaged substrates [7,9]. Proteolysis of damaged proteins occurs
primarily in the cytosol [10,11]. Here, ubiquitinylated, misfolded,
oxidized, or otherwise damaged proteins are recognized by the protea-
some [12] and cleaved into peptides by active centers located in the
proteasome 20S catalytic core [10]. The active proteolytic centers dis-
play three major speciﬁcities designated chymotrypsin-like [ChT-L],
trypsin-like [T-L], and post-glutamyl, peptide-hydrolyzing [PGPH],
reﬂecting the divergent chemical properties of the amino acid residues
on the carboxyl side of the scissile bond [10].
Stress resulting from protein damage challenges both HSPs and the
UPS by ﬁrstly increasing the load of substrates destined for degradation,
and secondly by directly damaging the proteasome and thereby
impairing its function [9]. Indeed, the reported decline in mouse
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duced increase in misfolded protein load and accompanying reduction
in proteasome efﬁciency [9,13,14]. In contrast, proteasome activity in
aged nakedmole-rats, like that in the cells of supercentenarians [15], re-
mains at high levels even though these rodents from an early age bear a
greater burden of proteotoxic stress fromoxidatively-damagedproteins
[6]. We postulate that as this species evolved mechanisms to prevent
damage from both the barrage of endogenous and environmental
stressors, they developed better maintenance of somatic integrity and
proteostasis and thereby longer lives.
RNA sequence analysis [RNA-Seq] reveals that many of the genes in-
volved in the regulation of UPS as well as those of HSPs are detected at
much higher levels in the nakedmole-rat relative tomice [16,17]. How-
ever, the particular expression pattern of UPS components as well as
HSPs can only partially explain the high and sustained levels of protea-
some activity in the naked mole-rat, such that young mole-rats exhibit
ﬁve-fold higher speciﬁc peptidase activities compared to physiologically
agedmice [18]. Moreover, RNA-Seq data do not explain the resilience of
naked mole-rat proteasomes to competitive inhibitors [6,19]. Although
published studies have documented that proteasome activity may be
elevated in response to mild oxidative challenge [9,20], to date there
has been no report of resistance of proteasomes to inhibition [20]. We
hypothesize that the naked mole-rat employs novel molecular mecha-
nisms to protect proteasome function and achieve sufﬁciently high
levels of catalytic activity necessary to effectivelymaintain proteostasis.
2. Materials and methods
2.1. Animals
This study used two similarly sized physiologically age-matched ro-
dent species namely Mus musculus (C57BL/6 mice; 4–6 months) and
H. glaber (naked mole-rats; 2–3 years). The mice were fed a standard
NIH-31 chow ad libitum and maintained in cohorts of four animals in
microisolator mouse cages at 25 °C, on a 12-h dark/light cycle. Naked
mole-rats were from the well-characterized colonies of Dr. Rochelle
Buffenstein housed at the University of Texas Health Science Center,
San Antonio [3]. Naked mole-rats were housed in simulated, multi-
chambered burrow systems under constant climatic conditions that
aimed to approximate their native habitat (30 °C; 30–50% RH). Naked
mole-rats were given an ad libitum supply of fresh fruits and vegetables
supplemented weekly with a high protein and vitamin enriched cereal
(Pronutro, South Africa). In this study, female mice were used to corre-
spond with past studies undertaken in this ﬁeld by our lab [13]. As the
subordinate naked mole-rats are sexually monomorphic [21], and we
found no sex speciﬁc differences in any of our measurements, we used
tissues from both male and females [18].
Animals were anesthetized with isoﬂuorane and euthanized by
cardiac exsanguination and the liver tissue was immediately excised
and ﬂash frozen in liquid nitrogen. All procedures involving animals
were approved by the Institutional Animal Care and Use Committee at
the University of Texas Health Science Center (San Antonio, TX).
2.2. Whole tissue lysates and subcellular fractionation
Mouse and nakedmole-rat liver lysateswere separated into cytosol-
ic, microsomal, and nuclear fractions using a modiﬁed Millipore Corp.
procedure as previously described [13,18]. These various fractions
were then used in peptidolytic assays.
2.3. Peptidolytic assay
Proteasome activity was measured using ﬂuorogenic model peptide
substrates (Boston Biochem, Boston, MA) speciﬁc for the ChT-L and T-L
active centers of the proteasome as previously described [18]. Parallel ac-
tivity assayswere performedwith varying concentrations of proteasomeinhibitors that represented four different classes of compoundswith dis-
tinctmodes of inhibitory action. These compoundsmodify active centers
using a boronate group (bortezomib [BZ] (Sigma-Aldrich, St. Louis,
MO)); an aldehyde (N-(benzyl-oxycarbonyl) leucinyl-leucinyl-leucinal
[MG132]); a vinyl sulfone (adamantane-acetyl-(6-aminohexanoyl)3-
(leucinyl)3-vinyl-(methyl)-sulfone [Adh (VS)]); or a lactone (lactacystin
[LC] (Calbio-chem/EMDMillipore, Billerica,MA)). Concentrations ranged
from 5 nM to 10 μM for BZ, 0.2 μM to 8 μM for LC, and 10 μM to 250 μM
for MG132 and Adh(VS) based on determinations from previous studies
[13,18,22,23]. Speciﬁc peptidolytic activity was presented as pmol of
released AMC in 1 min per 1 μg of total protein in the test sample. This
was determined after generating a standard curve using serial dilutions
of 1 mM AMC and measuring the ﬂuorescence using a Spectra-Max
Multi-mode microplate reader (Molecular Devices, Sunnyvale, CA) as
previously described [18].
The IC50 concentration was determined as the concentration of
inhibitor that reduced proteasome activity by 50%. For that purpose
exponential decay or sigmoidal functions were ﬁtted to the titration
data and the corresponding IC50 extracted (OriginPro, OriginLab Corp
or CompuSyn).
2.4. Crossover assays
A partial proteasome puriﬁcation of ﬁve separate naked mole-rat
and ﬁve mouse samples was performed using high-speed centrifuga-
tion [27,28]. Brieﬂy, the samples were centrifuged at 100,000 × g in an
S120 AT-2 (Sorvall) rotor for 5 h. The supernatant was decanted and
pooled, while the pellet was re-constituted in 50 mM Tris, pH 7.4 con-
taining 20% glycerol and 1 mM DTT. The pellet was left on ice for
30 min and then centrifuged again for 5 min at 16,000 × g. Protein con-
tent wasmeasured using the BCA Protein Assay Kit (Pierce, Thermo Sci-
entiﬁc, Rockford, IL, USA) and the peptidolytic assay for ChT-L activity
described above was performed starting with a 1:1 ratio of mouse or
nakedmole-rat puriﬁed proteasome to nakedmole-rat ormousepooled
supernatant. We also performed these experiments using puriﬁed
human 26S proteasome and yeast 20S proteasome (Enzo Life Sciences,
Plymouth Meeting, PA, USA). Parallel with these samples, supernatants
alone, and original mouse and naked mole-rat cytosolic fractions were
tested on the same 96-well plate used for the assay.
2.5. Size-exclusion spin ﬁltration
The size-exclusion ﬁltration procedure was performed according to
the manufacturer's instructions (Amicon Microcon ultracel YM-3 cellu-
lose ﬁlter, 3000 Da) (EMDMillipore, Billerica, MD, USA). Brieﬂy, 500 μL
of supernatant prepared as described under “Crossover Assay” was
placed on the ﬁlter and spun at 14,000 × g for 30 min (3 × 10 minute
washes). The ﬁltrate was collected and then the sample reservoir was
upended, and spun for 3 min at 14,000 × g to collect the retentate. Pro-
tein content was measured using the BCA Protein Assay Kit (Pierce,
Thermo Scientiﬁc, Rockford, IL, USA) and ChT-L activity was measured
as described previously using a 1:1 mouse or naked mole-rat puriﬁed
proteasome to nakedmole-rat pooled supernatant, retentate, or ﬁltrate.
2.6. Atomic force microscopy (AFM) imaging
Chromatographic fractions showing inhibition resistance (see
below), puriﬁed human 20S proteasome, and their mixture were sub-
jected to AFM imaging with tapping (oscillating) mode in liquid using
the Multimode Nanoscope IIIa AFM (Bruker) as previously described
[24]. Brieﬂy, 3 μL of sample containing 2 ng of h20S or undiluted fr. 23,
or a mixture of both, was deposited on freshly cleaved muscovite mica
and left for 2–3min at room temperature to allow for electrostatic bind-
ing to mica. Then, the sample was overlaid with 30 μL of imaging buffer
(5 mM Tris/HCl, pH 7.0), and subjected to AFM imaging. Oxide-
sharpened silicon nitride tips on cantilevers with a nominal spring
2062 K.A. Rodriguez et al. / Biochimica et Biophysica Acta 1842 (2014) 2060–2072constant of 0.32 N/mmounted in thewet chamber (Bruker Corp.) were
used for imaging. The resonant frequencywas tuned to 9–10 kHz,with a
drive voltage of 200–500 mV. To minimize “tapping” force interference
with the imagingmolecules, relatively high values of the set point, 1.5 V
to 1.9 V, were applied. Fields of 0.56 μm2 to 1 μm2were scanned at a rate
of 3.05 Hz with trace and retrace images collected with a resolution of
512 × 512 pixels. The images were processed only with the standard
plane-ﬁt and ﬂattening; therefore they should be considered as “raw”.
For display purposes the brightness and contrast of the imageswere ad-
justed and the occasional scan lines were removed with the Nanoscope
software. Morphometric analysis of particles was performed with the
grain analysis function in SPIP software (Image Metrology). To detect
distinct classes of particles, the Peak Analyzer function was applied to
the footprint area of all particles followed by hierarchical cluster
analysis executed on footprint area, height, aspect, perimeter, and
ﬁber length as unique and independent morphometric parameters
(OriginPro). A new class of objects characterized by the set of identiﬁed
morphometric parameters representing complexes of the cytosolic fac-
tor with 20S proteasomewas then sourced to the speciﬁc objects in the
original AFM images. As a self-test, the method correctly identiﬁed the
top view and side view proteasomes in samples containing only 20S
particles and in the mixture with fr. 23.
2.7. Multiplex Western blot analysis of heat shock proteins
Tissue lysates or sub-cellular fractions were separated in 12% SDS-
PAGE (Biorad Life Sciences, Hercules, CA) and transferred to nitrocellulose
membranes (Biorad Life Sciences, Hercules, CA). The membranes were
probed with antibodies against the following proteins: HSP110 (rabbit,
SPA-1101, 1:5 K), HSP90 (mouse, SPA831, 1:20 K), HSP70/72 (mouse,
SPA810, 1:10 K), HSP40 (HDJ1) (rabbit, SPA400, 1:2.5 K), HSP25/HSPB1
(rabbit, SPA801, 1:10 K) (Enzo Life Sciences, Plymouth Meeting, PA,
USA). We also used antibodies against HSC70 (mouse, sc-7298, 1:10 K)
(Santa Cruz Biotechnology, Santa Cruz, CA, USA). Blots were stained
with Ponceau-S to measure total protein load. Primary antibodies were
detected using anti-mouse IRDye 680LT, or anti-rabbit IR Dye800 CW
(Li-Cor) conjugated antibodies. Secondary antibodies were incubated at
1:10 K (anti-rabbit) or 1:20 K (anti-mouse) for 2 h at room temperature
and images were captured using the Odyssey Imaging System (Li-Cor,
Lincoln) for IRDye 680LT, IR Dye800. Immunoblots were quantiﬁed
using the ImageJ public domain Java image processing program (http://
rsbweb.nih.gov/ij/).
2.8. Gel ﬁltration chromatography
The 5-h supernatant was fractionated with gel ﬁltration chromatog-
raphy on a Superose 6 GL 10/30 column (GE Healthcare) ﬁtted into aB
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Fig. 1. Proteasomes from naked mole-rat [NMR] cytosol show resistance to proteasome speciﬁ
increasing concentrations of inhibitors representing four different classes of the compounds: (A
BZ. To compare the inhibition resistance between NMR (solid symbols) and mouse (open sym
required to ablate 50% of activity. The IC50 for (A) MG132 was 15×, (B) Adh(VS) 22×, (C) L
Table 1 for IC50 values. Calculations are based on ChT-L activity assessments from lysates of atBioCad Sprint (Perseptive Biosystems) HPLC. A 100 μL sample of ap-
proximately 2 μg/μL protein concentration was loaded. Chromatograms
were developed with a column buffer (50 mM Tris/HCl pH 7, 20%
glycerol) using 0.4 mL/min ﬂow rate. The volume of collected fractions
was 500 μL. About 48 fractions per chromatogram were collected.
Fractionation progress was monitored with absorption readings at 260
and 280 nm. The apparent molecular weight of separated proteins
was determined based on elution volumes of a set of gel ﬁltration
markers (Bio-Rad) ranging from 1350 (vitamin B12) to 670,000 Da
(bovine thyroglobulin).
Concentration of protein in fractions was determined with a BCA
assay (Pierce, Thermo Scientiﬁc, Rockford, IL, USA). Fractions were
concentrated as necessary using a Centricon 3000 Da cutoff ﬁlter
(Amicon Microcon Ultracel YM-3 cellulose ﬁlter; see Size-exclusion
spin ﬁltration section above; EMD Millipore, Billerica, MA, USA) and
the peptidolytic assay for ChT-L activity was performed as described
above (see Peptidolytic assay, main and supplementary text) with 0
and 20 μM of MG132.
2.9. In vitro depletion assays
Anti-HSP72 (Enzo, SPA-810), anti-HSP40 (Hdj1) (Enzo, SPA-
400), anti-HSP25 (Enzo, SPA-801), or anti-HSP90 (Enzo, SPA831)
speciﬁc anti-bodies were added in increasing concentrations ranging
from 10 pg to 400 pg (made as serial dilutions from the original stock
using PBS with 50% glycerol) to either naked mole-rat cytosolic ly-
sates or naked mole-rat supernatants separated from these lysates
(see Crossover assays above). Because of the sequence similarity
between mice and naked mole-rats of the key chaperones measured
in this study, it was assumed that the antibodies could recognize the
targeted protein in each species. For chemical inhibition of HSP72,
increasing concentrations of VER155008 (25 nM to 1000 nM,
Tocris Bioscience, UK) and piﬁthrin-μ (10 μM to 1000 μM; both
Calbiochem/EMDMillipore, Billerica, MA USA) were added to lysates
or supernatants in this manner. Next, the mixture was incubated at
30 °C for 1 h in the presence of 1 mM ATP. Immediately, the antibod-
ies or small-molecule inhibitors and puriﬁed human 26S proteasome
or 5 h-naked mole-rat partially puriﬁed proteasome as necessary
were added to the sample mixture. Then ChT-L activity was tested
as described above using Suc-LLVY-AMC in the presence or absence
of 20 μM of MG132.
2.10. Immunoprecipitation assay
Immunoprecipitation was performed with the Protein A/G PLUS-
Agarose Immunoprecipitation Reagent (Santa Cruz Biotechnology, Santa
Cruz, CA) using the protocols suggested by Enzo (www.enzolifesciences.C
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c competitive inhibitors. Dramatically different ChT-L activity was evident in response to
) an aldehyde, MG132; (B) a vinyl sulfone, Adh(VS); (C), a lactone, LC and (D) a boronate,
bols), we calculated the IC50 value, which corresponds to the concentration of inhibitor
C 40×, and (D) BZ 163× greater in NMR samples compared to those of mice. See also
least 3 mice or 6 NMRs.
Table 1
NMRproteasome ChT-L and T-L activities in the cytosolic fraction only showed remarkable
resistance to competitive inhibition as indicated by signiﬁcant differenceswhen compared
to mouse values. IC50 values are indicated in μM ± S.E.
Fraction/inhibitor ChT-L IC50 (μM) T-L IC50 (μM)
NMR MS NMR MS
Cytosolic/Adh (VS) 125.0 ± 5.6⁎ 5.56 ± 1.57⁎ 80.6 ± 2.5⁎ 16.2 ± 1.9⁎
Cytosolic/MG132 122.0 ± 5.5⁎ 8.22 ± 2.75⁎ 71.4 ± 8.7⁎ 14.6 ± 4.4⁎
Cytosolic/LC 6.15 ± 1.4⁎ 0.156 ± 0.005⁎ – –
Cytosolic/BZ 2.45 ± 0.74⁎ 0.015 ± 0.004⁎ – –
Microsomal/MG132 1.79 0.99 3.01 6.63
Nuclear/MG132 6.49 ± 2.70 4.6 ± 1.62 2.70 ± 1.4 12.8 ± 4.7
– = no data; Adh (VS) = adamantane-acetyl-(6-aminohexanoyl)3-(leucinyl)3-vinyl-
(methyl)-sulfone; MG132 = N-(benzyl-oxycarbonyl) leucinyl-leucinyl-leucinal;
LC = lactacystin; BZ = bortezomib.
⁎ p N 0.05.
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1 μg of anti-HSP70/72 antibodies (Enzo, SPA-801) per 100 μL of mouse
or naked mole-rat liver lysates (ﬁnal concentration 1 mg/mL).
After an overnight incubation at 4 °C of the immune complex, the
protein A/G beads were added and incubated for 2 h at 4 °C. The
beads were collected by microcentrifugation, washed 5× with PBS,
resuspended in 2× Laemmli reducing running buffer (4% SDS, 20%
glycerol, 10% 2-mercaptoethanol, 0.004% bromophenol blue, 0.125 M
Tris HCL; 95 °C for 5 min) and then subjected to SDS-PAGE separation
under denaturing conditions. The gels were transferred to PVDF mem-
brane and then tested with the same antibodies against HSP90, HSP72,
HSP40, and HSP25 used in previous Western blots and antibodies for
proteasome subunits, RPT5 (Enzo, mouse PW8770, 1:2 K), and α7
(Enzo, mouse PW8110, 1:5 K). HRP-conjugated secondary antibodies
for goat, rat, or rabbit (Santa Cruz) were used to visualize the immuno-
reaction using the ECL Prime Western Blotting Detection Reagent, a
chemiluminescent substrate (Amersham, Buckinghamshire, UK). Immu-
noblots were visualized using the Typhoon 9410 variable mode imager
or on X-ray ﬁlm (GE Healthcare).BA
Cytosolic - TL Microsom
NuclearCytosolic - TL
Fig. 2.Trypsin-like activity of proteasome inNMRcytosolic fractionswasmore resistant to comp
However, resistancewas not observed in themicrosomal or nuclear fractions of either species. (
both MG132 (top) and Adh(VS) (bottom) than that in the mouse cytosol. See also Table 1. (B)
found in the microsomal or nuclear fractions as tested with MG132. See also Table 1.2.11. Protein identiﬁcation by mass spectrometry
Proteins were separated by 1-D SDS-PAGE and proteins in each gel
lane were digested in situ with trypsin (Promega). The digests were
analyzed by capillary HPLC electrospray ionization tandem mass spec-
trometry (HPLC-ESI-MS/MS) on a Thermo Fisher Orbitrap Velos mass
spectrometer. The MS data were searched against the rodent subset of
the NCBInr protein database (NCBInr_20130102; 316,972 sequences)
by Mascot (Matrix Science). The Mascot results were subjected to a
subset search by X! Tandem followed by determination of probability
assessments of the peptide assignments and protein identiﬁcations by
Scaffold (Proteome Software).
2.12. Statistical analysis
A two-tailed Student's t-test on two different statistical platforms
(Microsoft Excel 2010; SigmaPlot) was used to determine signiﬁcant
differences in the means for the peptidolytic assays and Western blot
quantitation. One-way ANOVA was used in the inhibition resistance
experiments to analyze the variances between species and fractions
while two and three-way ANOVAs were used to test variance when
comparisons between treatments, species, and concentration were
necessary (SigmaPlot). Statistical signiﬁcance was set at the p b 0.05
level. All pairwise multiple comparison procedures used the Bonferroni
and Holm–Sidak corrections to counteract the probability of false
positives.
3. Results and discussion
3.1. Naked mole-rat proteasomes are resistant to proteasome inhibition
To test this hypothesis, wemeasured proteasome activity in the var-
ious subcellular fractions of liver lysates of mice and mole-rats when
treated with several proteasome-speciﬁc small molecule inhibitors,
namely MG132 [Adh(VS)] [25], [BZ] [22], and LC [23]. These well-al- ChT-L Microsomal- T-L
- ChT-L Nuclear- T-L
etitive inhibitors thanmouse proteasome, although less profoundly than theChT-L activity.
A) Based on IC50 values, the proteasome inNMR cytosol is about 5 times less susceptible to
In contrast, no signiﬁcant differences in inhibitor resistance between NMR and MS were
2064 K.A. Rodriguez et al. / Biochimica et Biophysica Acta 1842 (2014) 2060–2072characterized competitive inhibitors bind to the proteasome catalytic
centers using distinct chemicalmechanisms. ChT-L activity is the prima-
ry target for all four inhibitors. BZ, an approved anti-cancer drug [26,27],
is regarded as the most speciﬁc for this peptidase activity. T-L activity is
known as a secondary target for both MG132 and LC [23], and Adh(VS)
inhibits all three peptidases with relatively similar efﬁciency. We
compared these peptidase activities in untreated and inhibitor-treated
samples. In sharp contrast to data acquired with mouse proteasomes,
we found that naked mole-rat proteasomes from cytosolic extracts
maintained ChTL activity when treated with speciﬁc competitive
proteasome inhibitors (Fig. 1).Remarkably, naked mole-rats required
15-fold higher concentrations to ablate 50% of ChT-L activity (the IC50)
for MG132, while the IC50 for Adh(VS) was 22-fold and that for LC was
40-fold than that for mice (Fig. 1; Table 1). Strikingly, the ChT-L IC50
concentration for BZ was more than two orders of magnitude (163-
fold) higher in the naked mole-rat than in mouse cytosolic extracts
(Fig. 1; Table 1). T-L activity also showed inhibition resistance to
MG132 and Adh(VS) with the T-L IC50 5-fold greater in naked mole-
rats compared to mice for both agents (Fig. 2A; Table 1).
Inhibition resistance was restricted to the cytosolic fraction since it
was not observed in themicrosomal or nuclear fractions of either species
(Fig. 2B; Table 1). Since the cytosolic fraction is most likely to encounter
cellular stressors, we concluded that cytosol-speciﬁc resistance to
proteasome inhibition observed in the naked mole-rat could be anNMR
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Fig. 3. An NMR cytosolic factor confers resistance to mammalian and yeast proteasomes from
periment set-up to evaluate if species differences in proteasome resistance to inhibition reﬂect
Crossover assays in Methods for details. Bottom panel: When ProtMS were resuspended in SN
SNMS displayed both lower activity and greater sensitivity to inhibition. Bars A and D represen
andD=ChT-L activity permg lysate) in the absence of any inhibitor. B and E reveal the change i
that in comparisonwithmouse, the proteasome in NMR cytosol is resistant to inhibition. Bars C
activity and acquired inhibition resistance (p b 0.05), whereas ProtNMR resuspended in SNMS sho
= 5). Bar G reveals that the SN alone had very low peptidolytic activity. (B) Human 26S protea
(solid bars) and pronounced resistance to 10 nM BZ (hatched bars) (* to *′, p b 0.003; ** to **′, p
proteasome [y20S]. SNMS did not show this effect. No signiﬁcant increase in activity in the presimportant component of the cytoprotective arsenal that underlies
naked mole-rat resilience against potentially harmful conditions [5].
3.2. Proteasome resistance is transferrable among species
To evaluatewhether the observed resistance to inhibitionwas an in-
trinsic property of the nakedmole-rat proteasome or is rathermediated
by speciﬁc factors within the intracellular milieu, we used a simple
“cross-over” experimental design (Fig. 3A). Mole-rats and mice
proteasomes were partially puriﬁed from the cytosolic fractions using
differential centrifugation [28,29] and the proteasome-enriched pellet
and the proteasome-depleted supernatant were separately retained.
The supernatant of both species had very low ChT-L activity (Fig. 3A,
bar G) conﬁrming efﬁcient removal of proteasomes from the cytosol.
As a next step, ChT-L activity was measured in the “reconstituted cyto-
sol” containing proteasome-depleted (SN) plus proteasome-enriched
(Prot) preparations from either species in a 1:1 ratio of the original pro-
tein contents. When the ProtNMR was resuspended in SNMS, it no longer
showed resistance to MG132, and also exhibited similar proteasome
speciﬁc activity to that observed in mouse lysates (Fig. 3A, bars C, F).
Conversely, ProtMS activity more than doubled upon mixing with the
SNNMR (Fig. 3A, bar F). Furthermore, the ProtMS, when incubated in
SNNMR, became resistant to inhibition thus mirroring the cytosolic pro-
teasome activity proﬁle of the naked mole-rat (Fig. 3A, bar C). TheseMs
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NMR they showed elevated activity and inhibition resistance, whereas ProtNMR exposed to
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and F demonstrate that when ProtMS were resuspended in SNNMR they exhibited elevated
wed both lower activity and greater sensitivity to inhibition (p b 0.05) (means± S.E.M.; n
somes [h26S] treated with SNNMR, but not SNMS or buffer, showed increased ChT-L activity
b 0.0004; means± S.E.M.; n= 6). (C) SNNMR conveyed inhibition resistance to the yeast
ence of SNNMR was detected (* and ** indicated p b 0.01; means ± S.E.M.; n = 3).
2065K.A. Rodriguez et al. / Biochimica et Biophysica Acta 1842 (2014) 2060–2072data reveal that both elevated proteasome activity of naked mole-rats
and inhibition resistance are not due to intrinsic proteasome properties
conferring a more stable and more efﬁcient proteasome, but rather, are
due to protectivemodulators of proteasomeactivitywithin the cytosolic
milieu.
We found not only that the cytosolic milieu modulated mouse
proteasome activity but also that the SNNMR conferred these same ef-
fects on both human and yeast proteasomes.Whenwe exposed puriﬁed
human 26S or yeast 20S proteasome to the SNNMR we noticed an en-
hanced resistance to BZ inhibition (Fig. 3B,C). Indeed levels of protea-
some activity and inhibition resistance, when treated with SNNMR in
these evolutionarily divergent species, converged to that observed in
naked mole-rats. Moreover, exposure of human 26S to increasing con-
centrations of SNNMR resulted in a systematic increase of ChT-L activityA
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protein concentration of mouse supernatant [SNMS] (open squares) did not result in acquiring
sistance was evident even at the lowest used SNNMR:h26S ratio (1:1, 250 ng of each componen
Chymotrypsin-like [ChT-L] activity of h26Swas rapidly and profoundly enhanced by the additio
ratio (right panel). However, treatmentwith the 8-fold excess of SNMS resulted in only 2-fold acti
(B) SNNMR was fractionated with a spin ﬁlter with 3000 Da pore cutoff membrane (top panel) o
activities of ProtNMR after treatment with 20 μMMG132, alone or with addition of the whole SN
3000 Da) or the 3000 Da ﬁltrate [FTNMR; molecules with apparent molecular weights lower than
with thewhole SNNMR (comparewith Fig. 2A, bottom panel) or with the RNMR, but notwith FTNM
ChT-L activity assay with h26S treated with 20 μMof MG132 (left bar) the inhibition resistance w
bar;MW N 100,000Da, n=5 each treatment). (C) The ChT-L activity of h26S proteasomewasma
SNNMR, as compared with SNMS or buffer (n = 6). (D) To test if the factor is heat liable we subje
treated SNs were then added to h26S and ChT-L proteasome activity and inhibition resistance w
conveyed by SNNMR strongly suggesting a protein nature of the proteasome-affecting factor (n =and inhibition resistance (Fig. 4A). In contrast, the treatment with
SNMS resulted in trivial increases in ChT-L activity at only the highest
ratio of SNMS to human 26S proteasome [h26S], and no inhibition resis-
tance at any concentration of SNMS (Fig. 4A). These data provide strong
evidence that componentswithin the nakedmole-rat cytosol protect its
proteasome from agents that commonly impair proteasome function.
This cytosolic factor is transferrable to other species and capable of
inducing similar protective and modulatory effects.
Both partially puriﬁed mouse proteasomes and puriﬁed human 26S
also showed marked increases in speciﬁc proteasome activity even in
the absence of chemical inhibition (Fig. 3A,B). The mechanism(s) facili-
tating this increase in activity are unknown and possibly modulation of
proteasome activity in the absence of inhibitory agents may be a
mammal-speciﬁc property for this was not evident when yeast 20SD
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R. Spin-ﬁltering the SNNMR through a 100,000 Da pore cutoff membrane, andperforming the
as conveyed by the SNNMR (middle bar; compare with Fig. 2B) but not by the ﬁltrate (right
rkedly inhibited by all three ﬁltrates, indicating that BZwas not signiﬁcantly sequestered by
cted SNNMR and SNMS to heat stress at temperatures ranging from 32 °C to 75 °C. The heat-
ere assessed with 10 nM BZ. Heat-treatment above 45 °C ablated the inhibition resistance
5).
Table 2
The inhibition resistance factorwas associatedwith highmolecularweightmolecule(s) thatwere preserved in a retentate after SN fractionation through a Centricon 3000. Nakedmole-rat
supernatant [SN], retentate [R], or ﬂow-through [FT] was added to proteasomes [Prot] of both species [ProtNMR or ProtMS]. Neither the partially puriﬁed proteasomes alone nor the
proteasomesmixedwith FT showed resistance to inhibitionwhen treatedwith a range ofMG132 concentrations. In contrast, addition of either the SNor R did convey inhibition resistance.
These data complement the results presented in Fig. 4B, showing expanded concentrations of MG132 tested as well as percent inhibition. Results are presented as pmol AMC/min/μg
protein. Statistical signiﬁcance is indicated in the table below (ANOVA, *, p b 0.05 to Prot; #, p b 0.05 to FT).
Conc. MG132 (μM)→ 0 10 20 50
Sample Mean ± SE Mean ± SE % inhibition Mean ± SE % inhibition Mean ± SE % inhibition
ProtNMR 514 ± 9 72 ± 13 86.0 43 ± 0.3 91.6 23 ± 1.0 95.5
ProtNMR + SN 1011 ± 15*# 488 ± 58*# 51.7 499 ± 71*# 50.6 327 ± 104*# 67.7
ProtNMR + R 785 ± 106*# 542 ± 181*# 31.0 479 ± 146*# 39.0 378 ± 104*# 51.8
ProtNMR + FT 237 ± 45 40 ± 18 83.1 27 ± 18 88.6 16 ± 13 93.2
ProtMS 201 ± 1.0 25 ± 0.1 87.6 17 ± 0.2 91.5 11 ± 0.1 94.5
ProtMS + SN 263 ± 2.0*# 126 ± 22*# 52.1 116 ± 20*# 55.9 84 ± 34*# 68.1
ProtMS + R 282 ± 28*# 178 ± 72*# 36.9 172 ± 70*# 39.0 89 ± 12*# 68.4
ProtMS + FT 117 ± 13 17 ± 0.3 85.5 15 ± 3.0 87.2 3.0 ± 1.9 97.4
2066 K.A. Rodriguez et al. / Biochimica et Biophysica Acta 1842 (2014) 2060–2072proteasomes where incubated with SNNMR (Fig. 3C). It is intriguing that
at least the inhibition resistance conveyed by the naked mole-rat cyto-
solic factor is universal from yeast to mammalian proteasomes.
3.3. Identiﬁcation of the naked mole-rat activation/resistance factor
We tested if the observed changes in proteasome function in the
presence of the SNNMR were conveyed by small molecules or speciﬁc
macromolecule(s) that directly interact with the proteasome and alter
its properties. The involvement of cytosolic “small molecules” was
ruled out by evaluating proteasome activity and inhibition resistance
in the presence of the ﬂow-through (i.e., metabolites, small peptides;
Fig. 4B) or retentate (proteins and other macro-molecules) after the
3-kDa cutoff spin ﬁltration of cytosols. When the mouse or naked
mole-rat proteasome was exposed to the retentate, it also exhibited a0
25
50
75
100
gel filtration fraction
%
 in
hi
bi
tio
n
A
*
*15
8
44 17
0
400
800
1200
1600
2000
17 22 27 32 3
* * *
* * * * * *
C
pm
ol
A
M
C
/m
in
/μ
g 
pr 1
58 44 17
Fig. 5.NMR proteasome resistance to inhibition was found in two gel ﬁltration fractions. Protea
ﬁltration fractions and proteasome-speciﬁc inhibition resistance was measured after treatmen
ProtNMR ChT-L activity from MG132 inhibition (*p b 0.05; mean ± S.E.M., n = 5). Although fr.
above A indicate elution of themolecularweight standards. (B) ChT-L activity (expressed permg
from inhibition by 10 nMBZwhen suspended in the resistance factor-enriched fr. 23 (#p b 0.01
fr. 23 ChT-L activity of h26S exposed to BZ was reduced only by 30%. (C) Naked mole-rat [N
chymotrypsin-like [ChT-L] activitywasmeasured after treatmentwith 20 μM,MG132 (“treated”
in the absence of ProtNMR (“no Prot”) (*p b 0.05; mean ± S.E.M.; n = 5). Only ProtNMR added t
inhibition, unlike ProtNMR re-suspended in SNNMR (*p b 0.02). Very low peptidolytic activity wsimilar degree of inhibition resistance to that observed when it was
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However, when proteasomes were treated with ﬁltrate alone, the
resistance was not observed (Fig. 4B; Table 2). Interestingly, when
we fractionated the supernatant with a 100-kDa cut-off ﬁlter and
then measured the peptidolytic activity in the presence of the ﬂow-
through, the inhibition resistance capability was removed suggesting
that this feature of the cytosolic factor was facilitated by a molecule
or a group of molecules larger than 100 kDa (Fig. 4B). To rule out se-
questration of the inhibitors or their degradation in the supernatant,
we pre-incubated BZ with SNNMR, SNMS and buffer alone. Then, we
recovered the BZ by spin ﬁltering each sample through a 3-kDa cutoff
membrane. Next, we tested the ChT-L activity of human 26S protea-
some treated with the obtained ﬁltrates. All three samples apparently
contained highly potent BZ (Fig. 4C), therefore we concluded that the0
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2067K.A. Rodriguez et al. / Biochimica et Biophysica Acta 1842 (2014) 2060–2072inhibitor is not substantially degraded, modiﬁed or sequestrated by
components of the supernatant.
Based upon these results we hypothesized that both proteasome ac-
tivation and inhibition resistance are conferred by cytosolic proteins. To
assess this we subjected bothmouse and nakedmole-rat lysates to heat
stress for 1 h at temperatures ranging from 32 °C to 75 °C. Human 26S
was not any longer protected from inhibition when treated with NMR
lysate exposed to temperatures higher than 45 °C (Fig. 4D). We
envisioned two possible scenarios: a) that multiple proteins present in
high levels in naked mole-rat but not in mouse cytosols create an envi-
ronment generally supporting activation and resistance, or that b) the
naked mole-rat cytosol contains a speciﬁc protein or a protein complex
that interacts with the proteasome, commanding its activation and
resistance.
In an attempt to identify the components of the SNNMR that confer
inhibition resistance, the 5-h supernatant was fractionated by gel ﬁltra-
tion chromatography. ProtNMR was added to each chromatographic
fraction and ChT-L activity was measured in the presence or absence
of the MG132 proteasome inhibitor. The presence of a distinct macro-
molecular resistance factor particle would be evident if only one or a
few fractions convey the resistance. The total loss of protective capabil-
ities after the cytosol fractionation would suggest that macromolecular
resistance factor is not stable to gel ﬁltration conditions or that the cyto-
solic environment in general is responsible for the protection. The po-
tential factor(s) conveying inhibition resistance were localized to onlyTable 3
Mass spectrometry of fractions 22 and 23 revealed the presence of several molecular chaperon
Identiﬁed proteins (8/223) Accessi
Inducible heat shock protein 70 (HSP72) [Heterocephalus glaber] gi|1324
Ubiquitin-like modiﬁer-activating enzyme 1 [Heterocephalus glaber] gi|3516
78 kDa glucose-regulated protein [Heterocephalus glaber] gi|3517
Inducible heat shock protein 70 [Mus musculus] gi|1184
Hsp90aa1 protein [Mus musculus] gi|1181
Heat shock protein 90 beta [Equus caballus] gi|1208
Protein disulﬁde-isomerase [Heterocephalus glaber] gi|3517
Stress-70 protein, mitochondrial [Mus musculus] gi|1624
Spectral counts (quantitative value) determined by Scaffold (v3) are shown in the table undertwo adjacent chromatographic fractions (fr. 22 and fr. 23) correspond-
ing to a relative molecular weight of about 100 kDa–160 kDa (Fig. 5A,
C). These two fractions were pooled, collectively called fr. 23, and used
in subsequent experiments. Puriﬁed human 26S proteasomes treated
with fr. 23 were clearly resistant to inhibition when challenged with
10 nM BZ (Fig. 5B). Therefore, we concluded that the resistance factor
present in fr. 23 is a stable macromolecule, capable of withstanding
the puriﬁcation procedure, and whose actions on the proteasome can
be transferred to other species.
Interestingly, studies examining changes in gene expression in re-
sponse to MG132 treatment reveal overlapping features with the heat
shock response signaling pathway [30]. As such, compounds or path-
ways that stimulate or maintain chaperone response could also aid in
the preservation of proteasome function and recognition of damaged
substrates. Western blot analyses revealed that expression levels of
three key chaperones, HSP72, HSP40, and HSP25, were signiﬁcantly
higher in naked mole-rat liver cytosolic fractions and 5-h supernatants
than in respective mouse samples (Figs. 6A,B, S1). The high levels of
these HSPs in naked mole-rats concur with the previously described
strong correlation between levels of molecular chaperones and species
longevity in reptiles, birds, and mammals [31,32]. Cytosolic abundance
of these key HSPs in nakedmole-rat tissuesmay contribute to enhanced
protection at the molecular, cellular, and whole animal levels against
the many potential stressors these subterranean-dwelling rodents en-
counter over the course of their lifespan, and may be responsible fores. For a complete list please see Table S1.
on number Molecular weight fr.22 fr. 23
2237 (+26) 71 kDa 28 27
99501 119 kDa 20 12
02099 72 kDa 10 5
90060 (+7) 70 kDa 8 6
42832 (+23) 66 kDa 8 7
2134 (+17) 82 kDa 7 8
06419 57 kDa 7 5
61907 (+9) 73 kDa 7 6
the columns labeled fr.22 and fr.23.
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2068 K.A. Rodriguez et al. / Biochimica et Biophysica Acta 1842 (2014) 2060–2072providing a protective intracellular resistant environment. Mass spec-
trometry analysis of the fr. 22 and fr. 23 contents, the chromatographic
fractions conferring inhibition resistance, revealed the presence of naked
mole-rat HSP72 (inducible heat shock protein 70, Table 3; Fig. S2; See
also Supplementary material Table S1). Consistently, Western blot anal-
yses detected a high level of HSP72 in fr. 21, fr. 22, and fr. 23. HSP40 was
also present (Fig. 6C) in these fractions. Although HSP25 was the most
abundant HSP in the cytosol and 5-h supernatants (Fig. 6A,B), this0
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2069K.A. Rodriguez et al. / Biochimica et Biophysica Acta 1842 (2014) 2060–2072antibodies for HSP40, HSP72, HSP90, and HSP25. Only anti-HSP72 and
anti-HSP40 altered sensitivity to inhibition (Fig. 7). With increasing
concentration of anti-HSP72, the activity of proteasome was also re-
duced (Fig. 8A,B). Since mass spectrometry revealed the presence of
HSP90 in fr. 23 (Table 3), we also tested the inﬂuence of speciﬁc anti-
HSP90 antibodies on proteasomes. This treatment had no effect on inhi-
bition resistance, nor did HSP90 co-precipitate with HSP72 in naked
mole-rat lysates (Fig. 7C,E). Collectively, these results conﬁrm a key
role for the canonical chaperone HSP72, and its co-chaperone HSP40
in the protection of naked mole-rat proteasome function.
To gain insight into the mode of action of the chaperones we
challenged HSP72 with two distinct inhibitors: piﬁthrin-μ [33] and
VER155008 [34]. Piﬁthrin-μ, like the neutralizing antibody, binds to
the substrate-binding domain of HSP72 [33,35] whereas VER155008
binds to the ATPase domain of HSP72 and prevents ATP hydrolysis
[34]. Intriguingly, only piﬁthrin-μ lessened both the inhibition
resistance and the increased proteasome activity associated with the
SNNMR (Fig. 7D; Fig. 9). On the contrary, VER155008 had no effect
upon sensitivity to inhibition or activity (Fig. 10). Divergent responses
to piﬁthrin-μ and VER155008 suggest that the resistance/activation fac-
tor function is independent on ATP hydrolysis, but possibly relies on the
substrate-binding domain of HSP72. Immunoprecipitation experiments
revealed that HSP72 was associated with both the 26S proteasome and
HSP40 (Fig. 7E), indicating direct interactions between this factor and
proteasome in naked mole-rats, and suggesting a critical role of the
HSP72/HSP40 co-chaperone relationship for the observed functions of
increased proteasome activity and inhibition resistance for this cytosolic
factor.
The potential actions of HSP72 and HSP40, as described above, differ
markedly from the well-established roles of these molecular chaper-
ones in proteostasis. HSP72 and HSP40 are known to participate in
chaperone mediated autophagy [CMA], protein refolding, the preven-
tion of protein aggregation as well as the unfolding and transport of
damaged proteins for proteasome-mediated degradation [36]. More-
over, it is well known that HSP40 commonly co-localizes with HSP72,
and that HSP40 regulates ATP-dependent HSP72 activity [37]. However,
no HSP has been previously shown to stimulate proteasome activity or
for that matter any other protease. A previous study has shown that in-
creased expression of HSP40 (Hdj1) can confer proteasome resistance
to inhibition after exposure to oxidative stress in an in vitro cell system
[38], which supports our in vivo ﬁndings. Nevertheless, such ﬁndings,
that HSPs protect the proteasome (or any other protease) from endog-
enous or environmental stressors or, even more surprisingly, from the
various well-documented proteasome-speciﬁc competitive inhibitors
that induce their inhibition using different mechanisms of action, in a
natural animal has not been documented. Moreover, the role of theseHSPs in proteasomemodulation and protection from inhibition is inde-
pendent of ATP, further alluding to a previously undocumented novel
mechanism for HSP72 action. The C-terminus sequence of NMR and
mouse HSP72 show several areas of weaker homology including
deletion of a 16 residue long C-terminal peptide in NMR (Fig. S3).
Since the C-terminal part of HSp 72 is responsible for interaction with
substrates and Hsp40, such differences may point at alternate binding
partners or different efﬁciency of substrate binding. Interestingly, a
strong presence of retinal dehydrogenase was detected in fractions 22
and 23 (Table S1). Although its detection may be simply a result of an
abundance of the enzyme, it might also be possible that changes in
redox status of NADH may play a key role in activating this chaperone
response. This possibility is supported by a recent ﬁnding that NADH
binds to the 26S proteasome without ATP [39] and so could be a part
of a larger chaperone-proteasome complex.
Despite the fact that mouse cytosolic lysates contain many of the
homologous HSPs, albeit at lower concentrations than those found in
the naked mole-rat supernatant, they do not appear to convey any of
the proteasome protective properties observed in the naked mole-rat
cytosol. This is apparent evenwhen the cytosolic lysates are concentrat-
ed, with the exception of a modest activation at the highest concentra-
tions of SNMS used (Fig. 4A). It is possible that other macromolecules
2070 K.A. Rodriguez et al. / Biochimica et Biophysica Acta 1842 (2014) 2060–2072also contribute to the unique properties of this nakedmole-rat cytosolic
factor and that this likely forms a complex with the proteasome.
3.5. Morphometric characterization of a complex between 20S proteasome
and the resistance factor
Finally, we used atomic force microscopy [AFM], a nondestructive
imaging technology capable of detecting the topography of single native
biomacromolecule to see if we could identify distinct complexes of pu-
riﬁed human 20S proteasomewith the resistance factor present in fr. 23
(Fig. 11). As previously found with AFM, the tube-shaped human 20S
proteasomes bound to a mica surface in two orientations, “standing”
(the majority) and “lying” [24]. AFM imaging rendered the standing
particles as round cone shaped objects (Fig. 11B top row). A small frac-
tion of the 20S proteasomes lay on their side and they were observed as
rectangular or slightly oval particles (Fig. 11Bmiddle row). AFM images
of fr. 23 presented as expected a complex mixture of particles of differ-
ent sizes that were smaller than proteasomes and devoid of large com-
plexes or aggregates (Fig. 11A inset). Following the mixing of puriﬁedFig. 11. Atomic force microscopy [AFM] imaging identiﬁed putative complexes between protea
particles in amixture of puriﬁed h20S proteasomewith a gel ﬁltration fr. 23 containing resistanc
puriﬁed h20Sproteasome and fr. 23 (gray columns). Insets showAFM images of particleﬁelds re
zoomed-in from the ﬁelds of h20S (top-view and side-view) and h20S–fr. 23mixture. The elong
new class of particles, which appeared onlywhen h20Swasmixedwith fr. 23. Tappingmode in
AFM images represents the height of the particles, with black color corresponding to the back
comprising a new class of particles present only in the mixture and centered around 360–380
(A, left brace; B top row) and lying side view (A, right brace B middle row) h20S. Between 200
in the mixture was 4.7% and the average size of the particles was 33 × 10 nm (length × widthhuman 20S proteasomes with the naked mole-rat supernatant fr. 23,
AFMproduced images of a heterogeneousmixture of particles. To deter-
mine if themixture contains a new class of particles besides those found
separately in fr. 23 and in the puriﬁed 20S proteasome preparation, we
performed morphometric analysis of images collected for each investi-
gated case followed by hierarchical cluster analysis. We found that
about 5% of the particles in the fr. 23 + 20S proteasome mixture were
classiﬁed as a distinct new population of elongated (33 nm long and
10 nm wide) objects (Fig. 11A and B bottom row). At the same time
slightly lower abundance of free proteasomes was also observed. Since
we could not consistently ﬁnd any other larger or uniquely shaped
molecules in themixture or changes in object abundance, the identiﬁed
particles most likely correspond to complexes of the resistance factor
with the core proteasome. The dimensions of the complex may imply
that the resistance factor binds tο the α ring of 20S proteasome since
the length of the side view proteasome alone is 15–18 nm [31].
Furthermore, the topography of the identiﬁed complexes indicated
that both α faces were saturated with the resistance factor. Likely, half
saturated complexes also existed but could have been obscured insome and resistance factor. (A) Frequency histogram of footprint area of the AFM detected
e factor (black columns) and algebraic sumof the particle counts obtained separatelywith
presentingh20S, fr. 23 and theirmixture. (B) A gallery of representative images of particles
atedmolecules representing presumed proteasome–resistance factor complexes form the
liquid was used to collect height images (see Materials andmethods). The gray scale in all
ground (0 nm) and white color corresponding to 20 nm. A gray dot line oval marks bins
nm2 (B, bottom row). Black braces indicate ranges of area sizes characteristic for upright
and 300 particles were analyzed for each case. Relative abundance of the new complexes
). Insets show fragments of AFM images of ﬁelds with respective particles.
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similarly sized protein particles in fr. 23. These exciting data support
our premise that the cytosolic factor complexes with proteasomes and
thereby bothmodulates their activity and protects them from inhibiting
agents.
4. Conclusions
Clearly, the preternaturally long-lived nakedmole-rats have evolved
certainmolecularmechanisms that contribute to their ability to prolong
good health and attenuate the aging process [1]. The high proteasome
content coupled with its distinctive composition in naked mole-rats,
that we previously described, may play an integral role in this regard
[18]. However, we describe here another important, complementary
mechanism. We report here for the ﬁrst time that naked mole-rats ex-
press high levels of key chaperones, HSP72, HSP40, and HSP25, even
in untreated tissues when compared to those of the mouse. Further
we present evidence suggesting the presence of a novel cytosolic factor
that contains two of these chaperones, and that not only protects pro-
teasome function against cell stressors but also enhances proteasome
performance. This factor may be a common constitutive feature of
long-lived species, or possiblymay be induced under speciﬁc stress con-
ditions in both naked mole-rats and other organisms. Our ﬁnding of a
transferable stable factor that protects a critical intracellular proteolytic
system may have profound therapeutic signiﬁcance. We envision that
this may guard against the many age-related diseases linked to a
dysfunction in proteostasis and the concomitant accrual of protein ag-
gregates, such as occurs in Alzheimer's and Parkinson's diseases. This
cytosolic factor may also ameliorate the well-documented decrease in
proteasome activity with age [13,14,40,41] and if used therapeutically
may thus promote prolonged healthspan and longevity in our own
aging population.
Supplementary data to this article can be found online at http://dx.
doi.org/10.1016/j.bbadis.2014.07.005.
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